Aleen Inc.
0.80
USD
-0.14
(-15.34%)
ISIN
CA0139221091
CUSIP
013922109
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Toronto Canada
- IPO Date
- Jun 6, 2025
- Website
- aleen.ca
- Similar Companies
- Business
- Aleen Inc. is a Canadian digital health and wellness technology company that develops artificial intelligence-powered platforms for preliminary health condition assessment, symptom evaluation, and personalized wellness intelligence. Founded in 2020 and headquartered in Ottawa, Ontario, Canada, the company operates within the healthcare technology sector, providing software solutions to individual consumers, corporate wellness providers, and telemedicine enterprises across Canada, the United States, Denmark, Turkey, the Baltic region, and the Middle East. Aleen Inc. offers a systematic portfolio of proprietary products and services, including: Aleen AI, a non-medical artificial intelligence system that generates preliminary health assessments and lifestyle insights by analyzing user-submitted symptoms, risk factors, and personal metrics; Personal Wellness Account, a centralized digital dashboard that allows individuals to store, visualize, and track longitudinal wellness trends; Smart Analytics, a data analysis suite designed for privacy-preserving health data visualization and trend analysis; Biomarker Data Layer, an infrastructure enhancement that allows AI agents to interpret and correlate complex biomarker datasets; and B2B API Integration Services, comprising scalable application programming interface packages and per-call integration modules that enable third-party telehealth platforms, healthtech applications, and wellness service providers to embed Aleen's intelligence engine into their native ecosystems. In recent corporate and operational developments, Aleen Inc. completed its public listing on the Canadian Securities Exchange under the ticker ALEN.U in June 2025 and broadened its international market reach with a listing on the Frankfurt Stock Exchange in February 2026. Over the past year, the company advanced its product line by deploying autonomous AI wellness agents, launching biomarker data integration layers for its Personal Account infrastructure, finalizing concept validation for its Smart Analytics features, and launching capital-raising initiatives seeking up to 30 million USD to fund ongoing artificial intelligence research, platform commercialization, and international expansion.